£107.98

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Price data last checked 63 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 28 days • 28 data points (No recent data available)

Historical
Generating forecast...
£107.98 £107.38 £107.51 £107.64 £107.77 £107.90 £108.04 08 April 2026 14 April 2026 21 April 2026 28 April 2026 05 May 2026

Price Distribution

Price distribution over 28 days • 2 price levels

Days at Price
Current Price
19 days 9 days · current 0 5 10 14 19 £107 £108 Days at Price

Price Analysis

Most common price: £107 (19 days, 67.9%)

Price range: £107 - £108

Price levels: 2 different prices over 28 days

Description

Multiple myeloma (MM) remains a challenge in oncology despite progress in conventional treatments and high dose chemotherapy. This second volume from Springer addresses the need for new, biologically-based treatment approaches to overcome resistance and improve patient outcomes. This text focuses on current translational research aimed at developing molecularly-based combination therapies. These advancements hold the potential to achieve high frequency and durable responses for a majority of patients. By looking at recent breakthroughs in genomics and proteomics, the book provides a deep look into the science driving modern MM research. Designed for medical professionals and researchers, this volume explores the transition from laboratory discovery to clinical application. It covers the latest developments in the field to help professionals stay informed about the evolving landscape of multiple myeloma therapy and the science behind new treatment strategies.

Key Features

Explores novel biologically-based treatment approaches designed to overcome resistance to current therapies.

Covers recent advances in genomics and proteomics specifically related to multiple myeloma research.

Focuses on translational research regarding molecularly-based combination therapies for better patient responses.

Provides insight into how new developments aim to improve long-term patient outcomes in oncology.

Detailed analysis of the transition from laboratory findings to clinical research applications.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
06 December 2012
Listed Since
14 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 11 Jun 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£84.29 08 Mar 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
98% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£150.17 12 Jun 2026
Treatment of Multiple Myeloma and Related Disorders
98% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 04 Jul 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
98% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 02 Jul 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
98% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.41 10 Mar 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
97% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£131.96 13 Jun 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£79.19 06 May 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.24 12 Jun 2026
Springer Multiple Myeloma and Plasma Cell Neoplasms Book
97% match

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Springer

£104.18 28 Apr 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
97% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£31.08 07 Mar 2026
Horizons in Cancer Research. Volume 73: Volume 73
97% match

Horizons in Cancer Research. Volume 73: Volume 73

£113.87 13 Jun 2026
Contemporary Management of Multiple Myeloma
97% match

Contemporary Management of Multiple Myeloma

Jaypee Brothers Medical Publishers

£11.49 07 Jul 2026
Recent Updates on Multiple Myeloma
97% match

Recent Updates on Multiple Myeloma

IntechOpen

£119.00 10 Mar 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
97% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£140.56 13 Jun 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
97% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Academic Press

£168.99 19 Jun 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
96% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£104.67 09 Mar 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
96% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£80.64 30 Jun 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.08 03 Jul 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£99.71 22 Apr 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
96% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£84.56 01 May 2026
Genetic and Molecular Epidemiology of Multiple Myeloma
96% match

Genetic and Molecular Epidemiology of Multiple Myeloma

Springer

£80.64 29 Jun 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£248.00 17 Jun 2026
Hematologic Malignancies: An Overview - Hematology Research
96% match

Hematologic Malignancies: An Overview - Hematology Research

Out of Stock 17 Apr 2026